Related Experiment Video
Updated: Feb 25, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Mechanism and prediction of HCC development in HBV infection
Weiqi Xu1, Jun Yu2, Vincent Wai-Sun Wong2
1State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
Insights
Chronic hepatitis B virus (HBV) infection is a major cause of liver cancer (HCC). Prediction scores help identify low-risk individuals, but their effectiveness varies across ethnicities and needs further validation with new biomarkers.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection is a primary driver of hepatocellular carcinoma (HCC) worldwide.
- Risk factors for HCC in chronic HBV patients include host and viral elements.
- Existing HCC prediction scores offer value in identifying low-risk individuals for reduced surveillance.
Purpose of the Study:
- To evaluate the performance of existing HCC prediction scores.
- To assess the applicability of these scores in diverse populations.
- To explore the potential of novel biomarkers in HCC risk stratification.
Main Methods:
- Review of existing literature on HCC risk factors and prediction models.
- Analysis of studies validating HCC prediction scores in different ethnic groups.
- Investigation of emerging genetic and virological markers for HCC.
Main Results:
- HCC prediction scores demonstrate high negative predictive value for low-risk groups.
- Conflicting results exist regarding score performance in Caucasian versus Asian populations.
- New genetic and virological markers show promise but are not yet in clinical use.
Conclusions:
- Current HCC prediction scores are useful but require population-specific validation.
- Further research is needed to integrate novel biomarkers into clinical practice for improved HCC risk assessment in chronic HBV patients.
Abstract:
Chronic hepatitis B virus (HBV) infection remains one of the leading causes of hepatocellular carcinoma (HCC) globally. Over the past few decades, the risk factors of HCC in patients with chronic hepatitis B have been well characterized, and can be divided into host and viral factors. A few groups have also derived and validated HCC prediction scores based on these risk factors. In general, the scores have high negative predictive value in identifying a low risk group who may not need HCC surveillance in the next 3-5 years. The scores have been tested originally in Asian patients, and results on their performance in the Caucasian population are conflicting. Furthermore, new research has identified genetic factors and new virological markers (e.g. hepatitis B surface antigen and core-related antigen levels) for HCC, but they are yet to be applied in routine clinical practice.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

